Overview

* RadNet ( RDNT ) Q3 revenue grows 13.4% yr/yr to $522.9 mln

* Adjusted EPS for Q3 misses analyst expectations

* Company revises full-year guidance upwards for revenue and EBITDA

Outlook

* RadNet ( RDNT ) raises 2025 Imaging Center revenue guidance to $1.9 bln-$1.93 bln

* Company increases 2025 Imaging Center adjusted EBITDA guidance to $276 mln-$284 mln

* RadNet ( RDNT ) lifts 2025 Digital Health revenue guidance to $85 mln-$95 mln

Result Drivers

* ADVANCED IMAGING - Strong growth in advanced imaging procedural volumes contributed to revenue increase

* NEW CENTERS & JOINT VENTURES - New center openings and expansion of health system joint ventures supported revenue growth

* DIGITAL HEALTH GROWTH - Digital Health segment revenue increased 51.6%, boosting overall company performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $522.9

Revenue mln

Q3 Miss $0.20 $0.22 (7

Adjusted Analysts

EPS )

Q3 EPS $0.07

Q3 Net $13.89

Income mln

Q3 $27.39

Income mln

from

operatio

ns

Q3 $495.48

Operatin mln

g

Expenses

Q3 $20.27

Pretax mln

Profit

Q3 Total $522.87

Service mln

Revenue

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for RadNet Inc ( RDNT ) is $80.00, about 2.1% above its November 7 closing price of $78.31

* The stock recently traded at 100 times the next 12-month earnings vs. a P/E of 110 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)